Yuliya Sharkovska

DPP-4 Inhibition on Top of Angiotensin Receptor Blockade Offers a New Therapeutic Approach for Diabetic Nephropathy

Markus Alter, Ina M. Ott, Karoline von Websky et al. · Kidney & Blood Pressure Research · 2012 · 150 citations

Medicine, Pharmacology, Pharmacotherapy +17

Blood pressure and glucose independent renoprotective effects of dipeptidyl peptidase-4 inhibition in a mouse model of type-2 diabetic nephropathy

Yuliya Sharkovska, Christoph Reichetzeder, Markus Alter et al. · Journal of Hypertension · 2014 · 103 citations

Medicine, Endocrinology, Pharmacology +16

Soluble Guanylate Cyclase Stimulation Prevents Fibrotic Tissue Remodeling and Improves Survival in Salt-Sensitive Dahl Rats

Sandra Geschka, Axel Kretschmer, Yuliya Sharkovska et al. · PLoS ONE · 2011 · 102 citations · Full text

Medicine, Cardiology, Pharmacology +16

Nitric oxide-independent stimulation of soluble guanylate cyclase reduces organ damage in experimental low-renin and high-renin models

Yuliya Sharkovska, Philipp Kalk, Bettina Lawrenz et al. · Journal of Hypertension · 2010 · 99 citations

Medicine, Cardiology, Pharmacology +12

The dipeptidyl peptidase inhibitor linagliptin and the angiotensin II receptor blocker telmisartan show renal benefit by different pathways in rats with 5/6 nephrectomy

Oleg Tsuprykov, Ryotaro Ando, Christoph Reichetzeder et al. · Kidney International · 2016 · 91 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17